Mostrar el registro sencillo del ítem

dc.contributor.authorAtienza Navarro, Isabel 
dc.contributor.authorMarco Delgado, Ángel José del 
dc.contributor.authorGarcía Pérez, María de los Ángeles
dc.contributor.authorRaya Marín, Álvaro
dc.contributor.authorGil, Carmen
dc.contributor.authorMartínez, Ana
dc.contributor.authorBenavente Fernández, Isabel 
dc.contributor.authorLubián López, Simón Pedro 
dc.contributor.authorGarcía Alloza, Mónica 
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2025-02-19T13:23:19Z
dc.date.available2025-02-19T13:23:19Z
dc.date.issued2024-10-16
dc.identifier.issn0753-3322
dc.identifier.issn1950-6007
dc.identifier.urihttp://hdl.handle.net/10498/35520
dc.description.abstractGerminal matrix-intraventricular hemorrhage (GM-IVH) is one of the most common complications of the preterm newborn. The pathology of the GM-IVH is not completely understood and even regions distant from the lesion area are severely affected. It has been suggested that cerebellar diaschisis may underlie the neurodevelopmental problems that many of these kids show, including cerebral palsy, attention deficit disorders or hyperactivity. Additionally, GM-IVH has no successful treatment. VP3.15 is a dual action phosphodiesterase 7 (PDE7) and glycogen synthase kinase-3β (GSK-3β) inhibitor that limits neuroinflammation and neuronal loss. Therefore, it might also provide a relevant tool to reduce complications associated with GM-IVH. We have used a murine model of GM-IVH to analyze the short and long-term effects of VP3.15 in brain pathology and behavioral complications. In our hands, the induction of unilateral GM-IVH to P7 CD1 mice results in a short-term (P14) compromise of the cerebellar neuronal population and Purkinje cells arborization, an increase of microglia burden in the nuclei and an overall increase of punctuate cerebellar hemorrhages. Whereas brain alterations are no longer observed in the long term (P110), these animals present overt hyperactivity when analyzed in the adulthood, supporting the long-term behavioral impairment. Also, hyperactivity significantly correlates with ipsi and contralateral cerebellar sizes, neuronal densities and myelin basic protein levels. Importantly, treatment with VP3.15 significantly reduces neuronal loss, Purkinje cells simplification, the presence of cerebellar hemorrhages, as well as hyperactivity. Altogether, our data support the neuroprotective effects of VP3.15 in GM-IVH of the PT.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceBiomedicine and Pharmacotherapy, Vol. 180, 2024es_ES
dc.subjectPreterm newbornes_ES
dc.subjectGerminal matrix-intraventricular hemorrhagees_ES
dc.subjectVP3.15es_ES
dc.subjectGlycogen synthase kinase-3β inhibitores_ES
dc.subjectPhosphodiesterase 7 inhibitores_ES
dc.titleVP3.15 reduces acute cerebellum damage after germinal matrix-intraventricular hemorrhage of the preterm newbornes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.biopha.2024.117586
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Internacional